Inventor · disambiguated record
Xiang-Ju Justin Gu
Also filed as: GU XIANG · GU XIANG-JU · GU XIANG-JU JUSTIN
9 granted patents·4 pending applications·39 citations·filing 2005–2024
84Inventor score
Top patents by PatentIndex Score
13 records- 0193US11207325B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2020·Granted Dec 28, 2021·3 cites·19 claims
- 0289US9580437B2Triazolopyrimidine compounds and uses thereofCHAN HO MAN·Filed 2015·Granted Feb 28, 2017·15 cites·20 claims
- 0386US7968557B2Substituted pyrrolo[2,3-2]pyrimidines as protein kinase inhibitorsNOVARTIS AG·Filed 2005·Granted Jun 28, 2011·12 cites·8 claims
- 0481US10689378B2Triazolopyridine compounds and uses thereofNOVARTIS AG·Filed 2017·Granted Jun 23, 2020·4 cites·18 claims
- 0581US10220036B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2015·Granted Mar 5, 2019·3 cites·26 claims
- 0679US10676479B2Imidazolepyridine compounds and uses thereofNOVARTIS AG·Filed 2017·Granted Jun 9, 2020·2 cites·10 claims
- 0775US11931363B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2021·Granted Mar 19, 2024·0 cites·22 claims
- 0865US2024216378A1Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0962US2019142837A1Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1057US2024368289A1Anti-acvr2a antibodies and uses thereofLAEKNA THERAPEUTICS SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1156US2024254239A1Depletion of activated hepatic stellate cells (hscs) and uses thereofLAEKNA THERAPEUTICS SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1251US12473273B2Quinoline compounds and compositions for inhibiting EZH2NOVARTIS AG·Filed 2021·Granted Nov 18, 2025·0 cites·19 claims
- 1344US11168327B2STEAP2 inhibitors for the treatment of liver cancersRES FOUND DEV·Filed 2018·Granted Nov 9, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Xiang-Ju Justin Gu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →